[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Influenza Vaccine Market Report 2018

March 2018 | 118 pages | ID: AE62BFB0411QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Influenza Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Influenza Vaccine for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Influenza Vaccine market competition by top manufacturers/players, with Influenza Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GSK
  • Sinovac
  • Changsheng
  • CCBIO
  • Aleph Biomedical
  • Sanofi
  • Lanzhou Institute Of Biological Product
  • Siobp
  • Hualan Bio
  • Tianyuan Bio-Pharma
  • Vaxtec
  • Hissen
  • Abbott
  • Novartis
  • Tasly&Jenner
  • Tiantan
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Children
  • Adults
  • Elderly
  • Pregnancy
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Influenza Vaccine Market Report 2018

1 INFLUENZA VACCINE OVERVIEW

1.1 Product Overview and Scope of Influenza Vaccine
1.2 Classification of Influenza Vaccine by Product Category
  1.2.1 Asia-Pacific Influenza Vaccine Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Influenza Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Trivalent Influenza Vaccine
  1.2.4 Quadrivalent Influenza Vaccine
  1.2.5 Other
1.3 Asia-Pacific Influenza Vaccine Market by Application/End Users
  1.3.1 Asia-Pacific Influenza Vaccine Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Children
  1.3.3 Adults
  1.3.4 Elderly
  1.3.5 Pregnancy
1.4 Asia-Pacific Influenza Vaccine Market by Region
  1.4.1 Asia-Pacific Influenza Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Influenza Vaccine (2013-2025)
  1.5.1 Asia-Pacific Influenza Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Influenza Vaccine Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC INFLUENZA VACCINE COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Influenza Vaccine Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Influenza Vaccine Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Influenza Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Influenza Vaccine (Volume and Value) by Type
  2.2.1 Asia-Pacific Influenza Vaccine Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Influenza Vaccine Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Influenza Vaccine (Volume) by Application
2.4 Asia-Pacific Influenza Vaccine (Volume and Value) by Region
  2.4.1 Asia-Pacific Influenza Vaccine Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Influenza Vaccine Revenue and Market Share by Region (2013-2018)

3 CHINA INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 China Influenza Vaccine Sales and Value (2013-2018)
  3.1.1 China Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Influenza Vaccine Revenue and Growth Rate (2013-2018)
  3.1.3 China Influenza Vaccine Sales Price Trend (2013-2018)
3.2 China Influenza Vaccine Sales Volume and Market Share by Type
3.3 China Influenza Vaccine Sales Volume and Market Share by Application

4 JAPAN INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Influenza Vaccine Sales and Value (2013-2018)
  4.1.1 Japan Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Influenza Vaccine Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Influenza Vaccine Sales Price Trend (2013-2018)
4.2 Japan Influenza Vaccine Sales Volume and Market Share by Type
4.3 Japan Influenza Vaccine Sales Volume and Market Share by Application

5 SOUTH KOREA INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Influenza Vaccine Sales and Value (2013-2018)
  5.1.1 South Korea Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Influenza Vaccine Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Influenza Vaccine Sales Price Trend (2013-2018)
5.2 South Korea Influenza Vaccine Sales Volume and Market Share by Type
5.3 South Korea Influenza Vaccine Sales Volume and Market Share by Application

6 TAIWAN INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Influenza Vaccine Sales and Value (2013-2018)
  6.1.1 Taiwan Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Influenza Vaccine Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Influenza Vaccine Sales Price Trend (2013-2018)
6.2 Taiwan Influenza Vaccine Sales Volume and Market Share by Type
6.3 Taiwan Influenza Vaccine Sales Volume and Market Share by Application

7 INDIA INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 India Influenza Vaccine Sales and Value (2013-2018)
  7.1.1 India Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Influenza Vaccine Revenue and Growth Rate (2013-2018)
  7.1.3 India Influenza Vaccine Sales Price Trend (2013-2018)
7.2 India Influenza Vaccine Sales Volume and Market Share by Type
7.3 India Influenza Vaccine Sales Volume and Market Share by Application

8 SOUTHEAST ASIA INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Influenza Vaccine Sales and Value (2013-2018)
  8.1.1 Southeast Asia Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Influenza Vaccine Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Influenza Vaccine Sales Price Trend (2013-2018)
8.2 Southeast Asia Influenza Vaccine Sales Volume and Market Share by Type
8.3 Southeast Asia Influenza Vaccine Sales Volume and Market Share by Application

9 AUSTRALIA INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Influenza Vaccine Sales and Value (2013-2018)
  9.1.1 Australia Influenza Vaccine Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Influenza Vaccine Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Influenza Vaccine Sales Price Trend (2013-2018)
9.2 Australia Influenza Vaccine Sales Volume and Market Share by Type
9.3 Australia Influenza Vaccine Sales Volume and Market Share by Application

10 ASIA-PACIFIC INFLUENZA VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 GSK
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Influenza Vaccine Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Sinovac
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Influenza Vaccine Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Changsheng
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Influenza Vaccine Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Changsheng Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 CCBIO
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Influenza Vaccine Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 CCBIO Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Aleph Biomedical
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Influenza Vaccine Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Aleph Biomedical Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Sanofi
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Influenza Vaccine Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Lanzhou Institute Of Biological Product
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Influenza Vaccine Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Lanzhou Institute Of Biological Product Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Siobp
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Influenza Vaccine Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Siobp Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Hualan Bio
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Influenza Vaccine Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Tianyuan Bio-Pharma
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Influenza Vaccine Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Tianyuan Bio-Pharma Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Vaxtec
10.12 Hissen
10.13 Abbott
10.14 Novartis
10.15 Tasly&Jenner
10.16 Tiantan

11 INFLUENZA VACCINE MANUFACTURING COST ANALYSIS

11.1 Influenza Vaccine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Influenza Vaccine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Influenza Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC INFLUENZA VACCINE MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Influenza Vaccine Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Influenza Vaccine Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Influenza Vaccine Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Influenza Vaccine Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Influenza Vaccine Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Influenza Vaccine Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Influenza Vaccine Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Influenza Vaccine Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Influenza Vaccine Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Influenza Vaccine Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Influenza Vaccine Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Influenza Vaccine
Figure Asia-Pacific Influenza Vaccine Sales Volume (K Doses) by Type (2013-2025)
Figure Asia-Pacific Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure Asia-Pacific Influenza Vaccine Sales (K Doses) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Influenza Vaccine by Application in 2017
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure Asia-Pacific Influenza Vaccine Market Size (Million USD) by Region (2013-2025)
Figure China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Influenza Vaccine Sales Volume (K Doses) and Growth Rate (2013-2025)
Figure Asia-Pacific Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Influenza Vaccine Market Major Players Product Sales Volume (K Doses)(2013-2018)
Table Asia-Pacific Influenza Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Influenza Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Influenza Vaccine Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Influenza Vaccine Sales Share by Players/Suppliers
Figure Asia-Pacific Influenza Vaccine Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Influenza Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Influenza Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Influenza Vaccine Revenue Share by Players
Figure 2017 Asia-Pacific Influenza Vaccine Revenue Share by Players
Table Asia-Pacific Influenza Vaccine Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Influenza Vaccine Sales Share by Type (2013-2018)
Figure Sales Market Share of Influenza Vaccine by Type (2013-2018)
Figure Asia-Pacific Influenza Vaccine Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Influenza Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Influenza Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Influenza Vaccine by Type (2013-2018)
Figure Asia-Pacific Influenza Vaccine Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Influenza Vaccine Sales Volume (K Doses) and Market Share by Region (2013-2018)
Table Asia-Pacific Influenza Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Influenza Vaccine by Region (2013-2018)
Figure Asia-Pacific Influenza Vaccine Sales Market Share by Region in 2017
Table Asia-Pacific Influenza Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Influenza Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Influenza Vaccine by Region (2013-2018)
Figure Asia-Pacific Influenza Vaccine Revenue Market Share by Region in 2017
Table Asia-Pacific Influenza Vaccine Sales Volume (K Doses) and Market Share by Application (2013-2018)
Table Asia-Pacific Influenza Vaccine Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure China Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table China Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table China Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure China Influenza Vaccine Sales Volume Market Share by Type in 2017
Table China Influenza Vaccine Sales Volume (K Doses) by Applications (2013-2018)
Table China Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure China Influenza Vaccine Sales Volume Market Share by Application in 2017
Figure Japan Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Japan Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Japan Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Japan Influenza Vaccine Sales Volume Market Share by Type in 2017
Table Japan Influenza Vaccine Sales Volume (K Doses) by Applications (2013-2018)
Table Japan Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Japan Influenza Vaccine Sales Volume Market Share by Application in 2017
Figure South Korea Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure South Korea Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table South Korea Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table South Korea Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure South Korea Influenza Vaccine Sales Volume Market Share by Type in 2017
Table South Korea Influenza Vaccine Sales Volume (K Doses) by Applications (2013-2018)
Table South Korea Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure South Korea Influenza Vaccine Sales Volume Market Share by Application in 2017
Figure Taiwan Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Taiwan Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Taiwan Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Taiwan Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Influenza Vaccine Sales Volume Market Share by Type in 2017
Table Taiwan Influenza Vaccine Sales Volume (K Doses) by Applications (2013-2018)
Table Taiwan Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Influenza Vaccine Sales Volume Market Share by Application in 2017
Figure India Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure India Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table India Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table India Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure India Influenza Vaccine Sales Volume Market Share by Type in 2017
Table India Influenza Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table India Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure India Influenza Vaccine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Southeast Asia Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Southeast Asia Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Influenza Vaccine Sales Volume Market Share by Type in 2017
Table Southeast Asia Influenza Vaccine Sales Volume (K Doses) by Applications (2013-2018)
Table Southeast Asia Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Influenza Vaccine Sales Volume Market Share by Application in 2017
Figure Australia Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Australia Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Influenza Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Australia Influenza Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Australia Influenza Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Australia Influenza Vaccine Sales Volume Market Share by Type in 2017
Table Australia Influenza Vaccine Sales Volume (K Doses) by Applications (2013-2018)
Table Australia Influenza Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Australia Influenza Vaccine Sales Volume Market Share by Application in 2017
Table GSK Influenza Vaccine Basic Information List
Table GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GSK Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure GSK Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure GSK Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Sinovac Influenza Vaccine Basic Information List
Table Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sinovac Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Sinovac Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Sinovac Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Changsheng Influenza Vaccine Basic Information List
Table Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Changsheng Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Changsheng Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Changsheng Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table CCBIO Influenza Vaccine Basic Information List
Table CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure CCBIO Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure CCBIO Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure CCBIO Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Aleph Biomedical Influenza Vaccine Basic Information List
Table Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Sanofi Influenza Vaccine Basic Information List
Table Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Sanofi Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Sanofi Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Lanzhou Institute Of Biological Product Influenza Vaccine Basic Information List
Table Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Siobp Influenza Vaccine Basic Information List
Table Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Siobp Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Siobp Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Siobp Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Hualan Bio Influenza Vaccine Basic Information List
Table Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Hualan Bio Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Hualan Bio Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Hualan Bio Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Tianyuan Bio-Pharma Influenza Vaccine Basic Information List
Table Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Market Share in Asia-Pacific (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Revenue Market Share in Asia-Pacific (2013-2018)
Table Vaxtec Influenza Vaccine Basic Information List
Table Hissen Influenza Vaccine Basic Information List
Table Abbott Influenza Vaccine Basic Information List
Table Novartis Influenza Vaccine Basic Information List
Table Tasly&Jenner Influenza Vaccine Basic Information List
Table Tiantan Influenza Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Dose) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Figure Manufacturing Process Analysis of Influenza Vaccine
Figure Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2017
Table Major Buyers of Influenza Vaccine
Table Distributors/Traders List
Figure Asia-Pacific Influenza Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Influenza Vaccine Price (USD/Dose) and Trend Forecast (2018-2025)
Table Asia-Pacific Influenza Vaccine Sales Volume (K Doses) Forecast by Region (2018-2025)
Figure Asia-Pacific Influenza Vaccine Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Influenza Vaccine Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Influenza Vaccine Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Influenza Vaccine Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Influenza Vaccine Revenue Market Share Forecast by Region in 2025
Figure China Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure South Korea Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Taiwan Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Australia Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Influenza Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure Asia-Pacific Influenza Vaccine Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Influenza Vaccine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Influenza Vaccine Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Influenza Vaccine Price (USD/Dose) Forecast by Type (2018-2025)
Table Asia-Pacific Influenza Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure Asia-Pacific Influenza Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories